RxDoctor Payments Data
★ My doctorsLook up a doctor →

Christen Cawley, PA

Medical · Pittsburgh, PANPI 1538560511

Payments from drug & device makers

$8,347in general payments, 2019–2025

Across 480 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Johnson & Johnson$780
  • Pfizer$490
  • Daiichi Sankyo Inc.$407
  • AstraZeneca$381
  • Incyte Corporation$309
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$8,18598%
  • Education$1622%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis68$1,077
Johnson & Johnson46$780
Pfizer32$490
Daiichi Sankyo Inc.18$407
AstraZeneca26$381
Incyte Corporation12$309
Lilly USA, LLC20$308
Bayer16$290
Merck14$288
Eisai Inc.12$253
Seagen Inc.14$251
Bristol Myers Squibb13$222
Karyopharm Therapeutics Inc.14$216
Jazz Pharmaceuticals Inc.10$202
Astellas Pharma US Inc12$199
Myovant Sciences Inc.9$151
Genentech USA, Inc.8$135
Boehringer Ingelheim6$127
GSK8$125
Amgen7$118
Global Blood Therapeutics, Inc.7$117
AbbVie6$115
Dova Pharmaceuticals9$112
Morphosys, US Inc.6$110
Tersera Therapeutics LLC4$109
Array Biopharma Inc6$102
Dendreon Pharmaceuticals LLC4$82
Tolmar Pharmaceuticals, Inc.3$65
Emmaus Medical, Inc.2$63
Sobi, Inc4$61
Clovis Oncology, Inc.4$59
Epizyme, Inc.3$53
G1 Therapeutics, Inc.4$52
Regeneron Healthcare Solutions, Inc.2$52
E.r. Squibb & Sons, L.L.C.3$51
CTI Biopharma Corp.3$47
Pharmacyclics LLC, An Abbvie Company3$46
Taiho Oncology, Inc.3$45
Heron Therapeutics, Inc.3$44
Exelixis Inc.3$41
Kyowa Kirin, Inc.2$39
Stemline Therapeutics Inc.2$38
Alnylam Pharmaceuticals Inc.2$38
Organon2$37
Gilead2$36
Sumitomo Pharma America, Inc.2$35
Deciphera Pharmaceuticals Inc.2$34
Servier Pharmaceuticals LLC2$33
Beigene USA, Inc.2$32
Macrogenics, Inc.2$32
AVEO Pharmaceuticals, Inc.2$32
Acrotech Biopharma Inc.1$29
Sanofi1$24
Adaptive Biotechnologies Corporation1$20
Mirati Therapeutics, Inc.1$19
Foundation Medicine, Inc.1$19
Pharmacosmos Therapeutics Inc.1$19
Agios Pharmaceuticals, Inc.1$18
GE HealthCare1$18
EMD Serono, Inc.1$14

How this compares

$8,347 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$3,996
Medicare patients
58
Services billed
71

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl108$979
SsdSilver Sulfadiazine16$241
Fluconazole15$151
Hydrocortisone12$83
Oxycodone Hcl12$76

Paid to pharmacies, not to this prescriber.

Other medical in Pittsburgh

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →